Caleb Cranney

Title: Innovations of Caleb Cranney in Proteome Analysis

Introduction

Caleb Cranney is an innovative inventor based in Provo, UT (US). He has made significant contributions to the field of proteomics through his groundbreaking patent. His work focuses on enhancing the efficiency and accuracy of multi-omic analysis, which is crucial for drug and biomarker discovery.

Latest Patents

Caleb Cranney holds a patent titled "Quantitative shotgun proteome, lipidome, and metabolome analysis by direct infusion." This invention provides methods and systems that utilize gas-phase separation with mass spectrometry analysis instead of traditional liquid chromatography. This advancement enables faster peptide, proteome, and multi-omic analysis. One of the key embodiments of this invention, known as Direct Infusion-Shotgun Proteome Analysis (DI-SPA), allows for the targeted quantification of over 500 proteins within minutes of mass spectrometry data collection, achieving approximately 3.5 proteins per second. This method offers a new approach to unbiased protein and proteome quantification without the need for liquid chromatography, significantly boosting throughput in studies that require the analysis of thousands of proteomes.

Career Highlights

Throughout his career, Caleb has worked with notable organizations, including the Wisconsin Alumni Research Foundation and the Medical College of Wisconsin, Inc. His expertise in mass spectrometry and proteomics has positioned him as a valuable contributor to the scientific community.

Collaborations

Caleb has collaborated with esteemed colleagues such as Jesse Meyer and Joshua J Coon. These partnerships have furthered advancements in the field of proteomics and multi-omic analysis.

Conclusion

Caleb Cranney's innovative work in proteome analysis exemplifies the potential of modern scientific techniques to enhance drug and biomarker discovery. His contributions are paving the way for more efficient and comprehensive analyses in the life sciences.